LITTLE ELM, Texas–(BUSINESS WIRE)–Retractable Technologies, Inc. (NYSE American: RVP) reports that it has reduced its workforce by approximately 22%. The reduction is due to the decreased need for domestic production and production support personnel. The staff reduction primarily affects the Company’s production, operations, and logistics departments. The reduction will result in an overall annualized savings … [Read more…]
KEYTRUDA plus chemotherapy reduced risk of disease progression or death by 46% in patients whose cancer was mismatch repair proficient (pMMR) and by 70% in patients whose cancer was mismatch repair deficient (dMMR), compared to chemotherapy alone Results from Phase 3 NRG-GY018 trial to be presented at Society of Gynecologic Oncology (SGO) 2023 Annual Meeting … [Read more…]
ROCHESTER, N.Y.–(BUSINESS WIRE)–Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration services, enterprise asset management services, and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it has purchased all of the capital stock of privately-held TIC-MS, Inc. (TIC-MS), effective March 27, 2023. The purchase price … [Read more…]
SAN DIEGO–(BUSINESS WIRE)–Cytonus Therapeutics, Inc. has expanded its Scientific Advisory Board with the appointment of Michael Houston, PhD, former Chief Scientific Officer of TriLink the leading mRNA Contract Research Organization. “It is a great privilege for Cytonus to be joined by Dr. Houston, who has contributed important advances in the field of mRNA therapeutics,” said … [Read more…]
BROOMFIELD, Colo.–(BUSINESS WIRE)–TransLogic™, a Swisslog Healthcare company and a leading supplier in transport automation, has evolved to maintain its supply chain and manufacturing offerings domestically. TransLogic™ boasts that its solutions are “Made in the USA,” leading to improved quality of systems, reduced lead times, and reduced costs for sourcing and engineering. “TransLogic is not just … [Read more…]
WALTHAM, Mass. & SAN FRANCISCO–(BUSINESS WIRE)–Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and the University of California, San Francisco (UCSF), will accelerate advanced cell therapies for difficult to treat conditions, including cancer, rare diseases, and other illnesses, from a newly opened cGMP manufacturing facility adjacent to UCSF Medical Center’s Mission … [Read more…]
DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.–(BUSINESS WIRE)–$IMV #CancerVaccine–IMV Inc. (NASDAQ: IMV; TSX: IMV), a clinical-stage company developing a portfolio of immune-educating therapies, based on its novel DPX platform, to treat solid and hematologic cancers, today announced changes to its board of directors as Shermaine Tilley, Ph.D., MBA has resigned from the Board of Directors (“Board”) … [Read more…]
IRVING, Texas–(BUSINESS WIRE)–McKesson Corporation (NYSE: MCK) will release its fourth-quarter and full-year fiscal 2023 financial results after market close on Monday, May 8, 2023. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live webcast will be available on … [Read more…]
CHICAGO–(BUSINESS WIRE)–Exicure, Inc. (Nasdaq: XCUR), historically an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets, today reported financial results for the year ended December 31, 2022 and provided an update on its business strategy and corporate progress. Corporate Update As previously reported, in September 2022, we announced a … [Read more…]
– OncoVerity licenses Cusatuzumab, a first-in-class anti-CD70 antibody, from argenx – Max Colao, MBA appointed as Chief Executive Officer and Dr. Clay Smith as Chief Medical Officer – OncoVerity closes $30M Series A financing AURORA, Colo.–(BUSINESS WIRE)–OncoVerity, a pioneer in applying advanced multiomic, data driven patient stratification to the development of human therapeutics in oncology, … [Read more…]
